[1]赵恩熙,李乐愚,李娜,等.基于“脾虚-浊瘀-热毒”理论探讨2型糖尿病铁死亡的科学内涵[J].陕西中医,2025,46(8):1077-1081.[doi:DOI:10.3969/j.issn.1000-7369.2025.08.013]
 ZHAO Enxi,LI Leyu,LI Na,et al.To explore the scientific connotation of ferroptosis in T2DM based on the theory of “spleen deficiency-phlegm and stasis-heat toxin”[J].,2025,46(8):1077-1081.[doi:DOI:10.3969/j.issn.1000-7369.2025.08.013]
点击复制

基于“脾虚-浊瘀-热毒”理论探讨2型糖尿病铁死亡的科学内涵

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年8期
页码:
1077-1081
栏目:
学术探讨
出版日期:
2025-08-05

文章信息/Info

Title:
To explore the scientific connotation of ferroptosis in T2DM based on the theory of “spleen deficiency-phlegm and stasis-heat toxin”
作者:
赵恩熙李乐愚李娜曾婷婷王宣懿CHAI GAU Yong(马来西亚)
(广州中医药大学附属中山中医院,广东 中山 528400)
Author(s):
ZHAO EnxiLI LeyuLI NaZENG TingtingWANG XuanyiCHAI GAU Yong
(Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Traditional Chinese Medicine,Zhongshan 528400,China)
关键词:
2型糖尿病脾虚-浊瘀-热毒铁死亡线粒体脂质过氧化物堆积氧化应激
Keywords:
T2DMSpleen deficiency-phlegm and stasis-heat toxinFerroptosisMitochondriaLipid peroxide accumulationOxidative stress
分类号:
R 587.1
DOI:
DOI:10.3969/j.issn.1000-7369.2025.08.013
文献标志码:
A
摘要:
铁死亡与2型糖尿病(T2DM)及其诸多并发症密切相关。T2DM属于中医“消渴”的范畴,脾虚、浊瘀、热毒是消渴的重要病理因素。T2DM中“铁死亡”的发生机制与中医“脾虚-浊瘀-热毒”的病机演变有异曲同工之妙。线粒体作为能量场所,与中医脾的功能相似,脾虚失运导致津液输布失常,浊瘀互结,热毒内壅,微观表现为线粒体形态功能失调,能量代谢失常,脂质过氧化物不能被还原反应代谢,Fe2+通过Fenton反应氧化脂质产生大量羟基自由基和活性氧,诱发细胞铁死亡,影响机体糖代谢功能。基于此,提出消渴的根本病机为本虚标实,治疗应以健脾益气为根本,化浊逐瘀为主要方法,逆转热毒为重要手段。现以铁代谢异常、脂质堆积、氧化应激为切入点,具化糖尿病铁死亡,阐释“脾虚-浊瘀-热毒”理论的现代医学内涵,以期为中医药防治T2DM及其并发症提供新的思路和方法。
Abstract:
Ferroptosis has a broad and profound relationship with the type 2 diabetes mellitus (T2DM) and its various complications.In traditional Chinese medicine,T2DM belongs to “Xiaoke”.“Spleen deficiency-phlegm and stasis-heat toxin”,an important pathogenesis of “Xiaoke”,is similiar to the mechanisms of ferroptosis in T2DM.Mitochondria,an energy-producing organelle,is comparable in function to the spleen in traditional Chinese medicine.The spleen deficiency leads to abnormal distribution of body fluids,combination of turbidity and stasis and accumulation of heat toxin.On the micro level,it indicates malformation and dysfunction of mitochondria,as well as abnormal energy metabolism.Lipid peroxides cannot be metabolized by the reduction reaction and Fe2+ oxidizes lipids in Fenton-reaction,resulting in a large amount of hydroxyl radical and ROS,which promotes ferroptosis and glycometabolism disorder.Based on the above,it is proposed that the fundamental pathogenesis of Xiaoke is “deficiency in origin and excess in superficiality”.In the treatment,which is based on invigorating spleen and replenishing qi,dissolving turbidity and removing stasis is the primary approach,and removing heat toxin is an important means.This paper focuses on the iron metabolism disorder,lipid accumulation and oxidative stress to explore ferroptosis in T2DM to explain the implication of the “spleen deficiency-phlegm stasis-heat toxin” in modern medicine,aiming to provide theoretical references for the prevention and treatment of T2DM and its complications with traditional Chinese medicine.

参考文献/References:

[1]刘湘慧,斯韬,梁婷,等.铁死亡发生机制及其在肝细胞癌中的作用研究进展[J].陕西医学杂志,2023,52(3):354-357.
[2]马志红,廉猛,苏才丽,等.铁死亡与肿瘤的研究进展[J].临床与实验病理学杂志,2018,34(11):1247-1251.
[3]JIANG X,STOCKWELL B R,CONRAD M.Ferroptosis:Mechanisms,biology and role in disease[J].Nat Rev Mol Cell Biol,2021,22(4):266-282.
[4]LI J,CAO F,YIN H L,et al.Ferroptosis:Past,present and future[J].Cell Death Dis,2020,11(2):88.
[5]SHA W,HU F,XI Y,et al.Mechanism of ferroptosis and its role in type 2 diabetes mellitus[J].J Diabetes Res,2021,2021:9999612.
[6]LI D,JIANG C,MEI G,et al.Quercetin alleviates ferroptosis of pancreatic β cells in type 2 diabetes[J].Nutrients,2020,12(10):2954.
[7]MIIKI A,RICORDI C,SAKUMA Y,et al.Divergent antioxidant capacity of human islet cell subsets:A potential cause of beta-cell vulnerability in diabetes and islet transplantation[J].PLoS One,2018,13(5):e196570.
[8]BRUNI A,PEPPER A R,PAWLICK R L,et al.Ferroptosis-inducing agents compromise in vitro human islet viability and function[J].Cell Death Dis,2018,9(6):595.
[9]HAEEISON A V,LORENZO F R,MCCLAIN D A.Iron and the pathophysiology of diabetes[J].Annu Rev Physiol,2023,85:339-362.
[10]MENG Z,LIANG H,ZHAO J,et al.HMOX1 upregulation promotes ferroptosis in diabetic atherosclerosis[J].Life Sci,2021,284:119935.
[11]WANG H,LIU D,ZHENG B,et al.Emerging role of ferroptosis in diabetic kidney disease:Molecular mechanisms and therapeutic opportunities[J].Int J Biol Sci,2023,19(9):2678-2694.
[12]WANG X,CHEN X,ZHOU W,et al.Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways[J].Acta Pharm Sin B,2022,12(2):708-722.
[13]李浩甲,杨文曲,韩冲芳,等.去铁胺对糖尿病大鼠心肌细胞铁死亡通路的影响[J].医学研究杂志,2020,49(9):116-119.
[14]FRIEDMANNANGELI J P,SCHNEIDER M,PRONETH B,et al.Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice[J].Nat Cell Biol,2014,16(12):1180-1191.
[15]刘羽茜,刘悦,孙宇衡,等.基于脾脏象理论探讨脾与线粒体相关性[J].中华中医药学刊,2019,37(6):1362-1364.
[16]刘友章,王昌俊,周俊亮,等.长期脾虚模型大鼠细胞线粒体的研究[J].中医药学刊,2006,25(3):391-394.
[17]刘文宾,吴迪炯,叶宝东,等.慢性再生障碍性贫血患者铁过载与中医血瘀证的相关性研究[J].中国中西医结合杂志,2018,38(1):38-41.
[18]吴迪炯,罗贇飞,刘文宾,等.慢性“髓劳”患者“血瘀证”与铁负荷过载的相关性研究[J].浙江中医药大学学报,2016,40(4):265-269.
[19]CHEN X,KANG R,KROEMER G,et al.Ferroptosis in infection,inflammation,and immunity[J].J Exp Med,2021,218(6):e20210518.
[20]SUN Y,CHEN P,ZHAI B,et al.The emerging role of ferroptosis in inflammation[J].Biomed Pharmacother,2020,127:110108.
[21]SALAMA S A,KABEL A M.Taxifolin ameliorates iron overload-induced hepatocellular injury:Modulating PI3K/AKT and p38 MAPK signaling,inflammatory response,and hepatocellular regeneration[J].Chem Biol Interact,2020,330:109230.
[22]熊曼琪,李惠林.脾虚是消渴病的重要病机[J].广州中医学院学报,1991,8(1):1-4.
[23]李乐愚,林慧,梅全喜,等.复方番石榴制剂对2型糖尿病模型大鼠空腹血糖及胰岛素敏感性的影响[J].时珍国医国药,2015,26(11):2644-2646.
[24]成金燕,李乐愚,林泽宏,等.复方番石榴制剂治疗超重肥胖2型糖尿病的疗效分析[J].广州中医药大学学报,2016,33(5):630-633.
[25]徐瑞颜,成金燕,李乐愚.复方番石榴合剂治疗超重肥胖型2型糖尿病疗效及对患者肠黏膜屏障功能的影响[J].陕西中医,2022,43(8):1045-1048.
[26]王泽,林兰,李晓文,等.中医药干预糖尿病前期临床研究概况[J].中华中医药杂志,2021,36(4):2191-2195.
[27]刘友章,王昌俊,刘静,等.四君子汤对脾虚大鼠肝、心肌、胃黏膜和骨骼肌细胞线粒体损伤的修复作用[J].中国临床康复,2006,(39):170-173,193.
[28]XIE D,LI K,FENG R,et al.Ferroptosis and traditional Chinese medicine for type 2 diabetes mellitus[J].Diabetes Metab Syndr Obes,2023,16:1915-1930.
[29]王向晶,周奕菁,黄科,等.参芪地黄汤通过GPX4信号通路调控糖尿病肾病小鼠铁死亡的机制研究[J].浙江中医药大学学报,2024,48(4):407-415.
[30]段航,曾凡,王林华,等.桃红四物汤调控Nrf2/Keap1/HO-1信号通路介导的铁死亡在膝骨关节炎中的作用机制[J].中药药理与临床,2024,40(7):10-15.
[31]杨芳,高素文,刘旋,等.丹参酮ⅡA通过调控p38MAPK/NF-κB信号通路减轻糖尿病雄性大鼠生殖损伤实验研究[J].陕西医学杂志,2024,53(5):610-615.
[32]岳星.化瘀祛湿方对早中期KOA铁死亡相关基因VEGFA、IL-6的影响[D].南宁:广西中医药大学,2024.
[33]张志达.黄芩素调控SLC7A11/GPX4轴抑制铁死亡预防糖尿病性骨质疏松的机制[D].广州:广州中医药大学,2022.
[34]刘清,王芳,张淑娟,等.白虎加人参汤对2型糖尿病大鼠抗氧化应激作用及机制研究[J].陕西中医,2024,45(9):1166-1171.
[35]黄璟夷,林俊,钟玉娇,等.葛根芩连汤对2型糖尿病合并非酒精性脂肪肝大鼠模型铁死亡干预作用研究[J].环球中医药,2024,17(7):1291-1298.

相似文献/References:

[1]李向辉,卢文杰.葛黄降糖汤治疗2型糖尿病合并颈动脉硬化临床研究*[J].陕西中医,2019,(5):580.
 LI Xianghui,LU Wenjie..Effect of Gehuang Jiangtang decoction on mellitus complicated with carotid arteriosclerosis in type 2 diabetes patients[J].,2019,(8):580.
[2]杨斯皓,马方霞,詹 云.一贯煎合六味地黄汤配合西药治疗2型糖尿病合并非酒精性脂肪肝临床疗效及对患者生活质量的评价*[J].陕西中医,2019,(8):1006.
 YANG Sihao,MA Fangxia,ZHAN Yun..Clinical efficacy and quality of life evaluation of Yiguanjian plus Liuwei Dihuang decoction with western medicine in the treatment of type 2 diabetes with nonalcoholic fatty liver disease[J].,2019,(8):1006.
[3]孙晓红,陈学彬△.芪精丹兰汤对伴有左心室舒张功能不全的2型糖尿病合并代谢综合征患者糖脂代谢、心率变异性的影响*[J].陕西中医,2019,(10):1336.
 SUN Xiaohong,CHEN Xuebin..Effect of Qijing Danlan decoction on glucose and lipid metabolism and heart rate variability in patients with type 2 diabetes mellitus complicated with MS with left ventricular diastolic dysfunction[J].,2019,(8):1336.
[4]訾 璐,胡小军△,王 玉,等.针刺中脘穴联合自拟茶方对2型糖尿病患者血糖水平的影响*[J].陕西中医,2019,(10):1460.
 ZI Lu,HU Xiaojun,WANG Yu,et al.Effect of zhong wan acupuncture combined with selfdesigned tea prescription on blood glucose level in patients with type 2 diabetes mellitus[J].,2019,(8):1460.
[5]文启友,周 伶,马若梦,等.化瘀利尿法论治2型糖尿病探析[J].陕西中医,2021,(6):761.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.021]
[6]谢兆桃,周卓宁,郑 鹏,等.从中焦论治2型糖尿病患者餐后血糖波动[J].陕西中医,2021,(6):764.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.022]
[7]胡全穗,伍宗明.运用中药药对配伍优化消渴病中医防治方案临床研究[J].陕西中医,2021,(8):1084.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.024]
 HU Quansui,WU Zongming.Clinical research on optimizing the TCM prevention and treatment of Xiaoke by using compatibility of herb-partners[J].,2021,(8):1084.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.024]
[8]卢 昉,刘晓霞,梁佩玲,等.清热益气降糖方对2型糖尿病患者胰岛α、β细胞功能的影响[J].陕西中医,2021,(10):1400.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.019]
[9]刘厚利,呼兴华,何 莉,等.基于数据挖掘许建秦治疗湿热内蕴型糖尿病用药规律分析[J].陕西中医,2021,(10):1455.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.035]
[10]陈继玲,任珍珍,王劭敏,等.玉泉丸合生脉散联合二甲双胍治疗气阴两虚证2型糖尿病临床研究[J].陕西中医,2021,(11):1553.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.013]
 CHEN Jiling,REN Zhenzhen,WANG Shaomin,et al.Efficacy of Yuquan pills with Shengmai powder and metformin tablets in the treatment of T2DM with deficiency of Qi and Yin[J].,2021,(8):1553.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.013]

备注/Memo

备注/Memo:
广东省基础与应用基础研究基金资助项目(2022A1515011307);广东省省级医疗卫生健康事业发展专项[中山卫健财(2024)9号];广东省中山市科技局第一批社会公益项目(2022B1131,2021B1066)
更新日期/Last Update: 2025-08-08